Swiss National Bank
ABUS icon

Swiss National Bank’s Arbutus Biopharma ABUS Stock Holding History

Swiss National Bank’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.28M Hold
283,400
– – ﹤0.01% 2063
2025
Q4 		$1.36M Buy
283,400
+7,100
+3% +$31.9K ﹤0.01% 2040
2025
Q3 		$1.25M Hold
276,300
– – ﹤0.01% 2067
2025
Q2 		$854K Hold
276,300
– – ﹤0.01% 2200
2025
Q1 		$964K Hold
276,300
– – ﹤0.01% 2146
2024
Q4 		$904K Hold
276,300
– – ﹤0.01% 2248
2024
Q3 		$1.06M Buy
+276,300
New +$1.06M ﹤0.01% 2188
2015
Q1 		– Sell
-16,900
Closed -$259K – 2547
2014
Q4 		$259K Buy
+16,900
New +$292K ﹤0.01% 2444

Other funds holding ABUS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Swiss National Bank's ABUS Position: Q1 2026 in Review

Swiss National Bank held its Arbutus Biopharma (ABUS) position steady in Q1 2026 at 283,400 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #2063.

Swiss National Bank first reported a position in ABUS in Q4 2014 and has held it in 8 quarters since. The position peaked at $1.36M in Q4 2025. 167 funds tracked by Wall St. Rank hold ABUS as of Q1 2026.

  • Swiss National Bank held 283,400 shares of Arbutus Biopharma worth $1.28M as of Q1 2026.
  • Swiss National Bank left its Arbutus Biopharma share count unchanged in Q1 2026.
  • Arbutus Biopharma made up ﹤0.01% of Swiss National Bank's portfolio in Q1 2026, its #2063 holding.
  • Swiss National Bank first reported a position in Arbutus Biopharma in Q4 2014 and has held it in 8 quarters since.
  • Swiss National Bank's Arbutus Biopharma position peaked at $1.36M in Q4 2025.
  • 167 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.